Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-03-06

Clinical Trial Update: Study of Etanercept in the Treatment of Psoriasis in Adult Subjects [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating etanercept for adult psoriasis, sponsored by Amgen, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Etanercept (etanercept)

Snippet

Sponsor: Amgen | Conditions: Inflammation, Psoriasis | Phase 3 | Status: COMPLETED